ovarian neoplasm
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We think that the non-coding rs2072590 variant may contribute to OC susceptibility by regulating the gene expression of HOXD1 and HOXD3.
|
29262571 |
2017 |
Malignant neoplasm of ovary
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We think that the non-coding rs2072590 variant may contribute to OC susceptibility by regulating the gene expression of HOXD1 and HOXD3.
|
29262571 |
2017 |
ovarian neoplasm
|
0.310 |
Biomarker
|
disease |
CTD_human |
Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
|
20852632 |
2010 |
Malignant neoplasm of ovary
|
0.310 |
Biomarker
|
disease |
CTD_human |
Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
|
20852632 |
2010 |
Hyperalgesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Pain, Burning
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
CUI: |
C0234238 |
Disease: |
Ache
|
Ache
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Radiating pain
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Pain, Splitting
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Pain, Crushing
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Hyperalgesia, Primary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Hyperalgesia, Secondary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Tactile Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Hyperalgesia, Thermal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Pain, Migratory
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Suffering, Physical
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Mechanical Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates.
|
21151121 |
2011 |
Colorectal Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.
|
31015462 |
2019 |
Glucose tolerance test
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic determinants of circulating GIP and GLP-1 concentrations.
|
29093273 |
2017 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, RNPC1 overexpression restrained the promotion of STARD13, CDH5, HOXD10, and HOXD1 knockdown on cell metastasis.
|
29733656 |
2018 |
Carcinoma, Ovarian Epithelial
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We think that the non-coding rs2072590 variant may contribute to OC susceptibility by regulating the gene expression of HOXD1 and HOXD3.
|
29262571 |
2017 |